Ataxia telangiectasia (AT) is a rare, inherited, neurodegenerative disorder that affects the nervous system, immune system, and other body systems. It is characterized by progressive difficulty with balance and coordination, telangiectasias (dilated blood vessels) on the skin and eyes, and a weakened immune system. Other symptoms may include difficulty speaking, hearing loss, and recurrent infections. AT is caused by a mutation in the ATM gene, which is responsible for producing a protein that helps to regulate cell division and repair damaged DNA.

Ataxia Telangiectasia (A-T) is a rare, inherited, progressive neurological disorder that affects the nervous system, immune system, and other body systems. Symptoms of A-T can vary from person to person, but typically include:

• Poor coordination and balance (ataxia)

• Slurred speech

• Delayed development

• Weakness in the arms and legs

• Poor fine motor skills

• Poor eye movement control

• Telangiectasias (dilated blood vessels) on the face, ears, and eyes

• Increased risk of infections

• Increased risk of cancer

• Slowed growth

• Cognitive impairment

• Seizures

• Abnormalities in the eyes, such as cataracts or glaucoma

Ataxia telangiectasia (A-T) is a rare, inherited, progressive neurological disorder caused by a mutation in the ATM gene. This gene is responsible for producing a protein that helps control the repair of damaged DNA. When the ATM gene is mutated, the body is unable to repair damaged DNA, leading to a wide range of symptoms, including ataxia (loss of muscle coordination), telangiectasia (dilated blood vessels), immune system dysfunction, and an increased risk of cancer.

Ataxia Telangiectasia (A-T) is a rare, progressive, genetic disorder that affects the nervous system, immune system, and other body systems. There is currently no cure for A-T, but treatments are available to help manage the symptoms and slow the progression of the disease. These treatments include physical therapy, occupational therapy, speech therapy, medications to reduce inflammation, and nutritional supplements. Additionally, regular monitoring of the patient's health is important to ensure that any changes in the patient's condition are addressed promptly.

1. Genetic mutation: Ataxia telangiectasia is caused by a mutation in the ATM gene.

2. Age: Ataxia telangiectasia is most commonly diagnosed in children between the ages of 2 and 5.

3. Family history: A family history of ataxia telangiectasia increases the risk of developing the condition.

4. Gender: Ataxia telangiectasia is more common in males than females.

5. Ethnicity: Ataxia telangiectasia is more common in people of Ashkenazi Jewish descent.

Ataxia telangiectasia (AT) is a rare, inherited, progressive neurological disorder that affects the nervous system, immune system, and other body systems. There is currently no cure for AT, but there are treatments available to help manage the symptoms. Medications such as muscle relaxants, anticonvulsants, and anti-inflammatory drugs may be prescribed to help reduce muscle spasms and improve coordination. Physical and occupational therapy can also help improve coordination and balance. In some cases, a feeding tube may be necessary to ensure adequate nutrition.